151 related articles for article (PubMed ID: 23461757)
1. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?
Chen M; Liu A; Ouyang Y; Huang Y; Chao X; Pi R
Expert Opin Investig Drugs; 2013 Apr; 22(4):537-50. PubMed ID: 23461757
[TBL] [Abstract][Full Text] [Related]
2. FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.
Xin YL; Yu JZ; Yang XW; Liu CY; Li YH; Feng L; Chai Z; Yang WF; Wang Q; Jiang WJ; Zhang GX; Xiao BG; Ma CG
Biosci Rep; 2015 Jul; 35(5):. PubMed ID: 26223433
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies.
Satoh S; Ikegaki I; Kawasaki K; Asano T; Shibuya M
Curr Vasc Pharmacol; 2014; 12(5):758-65. PubMed ID: 24923440
[TBL] [Abstract][Full Text] [Related]
4. Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
Ding J; Li QY; Yu JZ; Wang X; Sun CH; Lu CZ; Xiao BG
Mol Cell Neurosci; 2010 Feb; 43(2):201-8. PubMed ID: 19913617
[TBL] [Abstract][Full Text] [Related]
5. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
Shenkar R; Shi C; Austin C; Moore T; Lightle R; Cao Y; Zhang L; Wu M; Zeineddine HA; Girard R; McDonald DA; Rorrer A; Gallione C; Pytel P; Liao JK; Marchuk DA; Awad IA
Stroke; 2017 Jan; 48(1):187-194. PubMed ID: 27879448
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Fasudil in preclinical models of pain.
Boyce-Rustay JM; Simler GH; McGaraughty S; Chu KL; Wensink EJ; Vasudevan A; Honore P
J Pain; 2010 Oct; 11(10):941-9. PubMed ID: 20338818
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.
Yan Y; Yu J; Gao Y; Kumar G; Guo M; Zhao Y; Fang Q; Zhang H; Yu J; Jiang Y; Zhang HT; Ma CG
Metab Brain Dis; 2019 Apr; 34(2):377-384. PubMed ID: 30552558
[TBL] [Abstract][Full Text] [Related]
8. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor.
Yu JZ; Ding J; Ma CG; Sun CH; Sun YF; Lu CZ; Xiao BG
J Neurosci Res; 2010 Jun; 88(8):1664-72. PubMed ID: 20077431
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase inhibitors: a patent review (2014 - 2016).
Defert O; Boland S
Expert Opin Ther Pat; 2017 Apr; 27(4):507-515. PubMed ID: 28048944
[TBL] [Abstract][Full Text] [Related]
11. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
12. Rho kinase inhibition by fasudil exerts antioxidant effects in hypercholesterolemic rats.
Ma Z; Zhang J; Ji E; Cao G; Li G; Chu L
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):688-94. PubMed ID: 21711379
[TBL] [Abstract][Full Text] [Related]
13. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats.
Ichikawa M; Yoshida J; Saito K; Sagawa H; Tokita Y; Watanabe M
Brain Res; 2008 Mar; 1201():23-33. PubMed ID: 18313036
[TBL] [Abstract][Full Text] [Related]
15. Exposure to the ROCK inhibitor fasudil promotes gliogenesis of neural stem cells in vitro.
Nizamudeen ZA; Chakrabarti L; Sottile V
Stem Cell Res; 2018 Apr; 28():75-86. PubMed ID: 29448133
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
17. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
[TBL] [Abstract][Full Text] [Related]
18. Intraradial administration of fasudil inhibits augmented Rho kinase activity to effectively dilate the spastic radial artery during coronary artery bypass grafting surgery.
Takagi T; Okamoto Y; Tomita S; Sato A; Yamaguchi S; Takuwa Y; Watanabe G
J Thorac Cardiovasc Surg; 2011 Aug; 142(2):e59-65. PubMed ID: 21397262
[TBL] [Abstract][Full Text] [Related]
19. Fasudil alleviates brain damage in rats after carbon monoxide poisoning through regulating neurite outgrowth inhibitor/oligodendrocytemyelin glycoprotein signalling pathway.
Wang L; Xu J; Guo D; Zhou X; Jiang W; Wang J; Tang J; Zou Y; Bi M; Li Q
Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):152-165. PubMed ID: 30916885
[TBL] [Abstract][Full Text] [Related]
20. Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma.
Impellizzeri D; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S
J Pharmacol Exp Ther; 2012 Oct; 343(1):21-33. PubMed ID: 22733360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
